Effectiveness of continuous glucose monitoring in patient management of Type 2 Diabetes Mellitus: an umbrella review of systematic reviews from 2011 to 2024
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a recent umbrella review demonstrated with moderate evidence certainty that CGM improves glycemic outcomes in T2DM (HbA1c mean difference with CGM, –0.40% [95% CI, –0.54 to –0.25]), irrespective of age and insulin-use status [88].”
From Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions (2025) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
How to perform a meta-analysis with R: a practical tutorial
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300117 · Cited by 5,827
McGuinness, L. A., & Higgins, J. P. T. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1411 · Cited by 5,579
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561
The PICO strategy for the research question construction and evidence search
Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007) · Revista Latino-Americana de Enfermagem · doi:10.1590/s0104-11692007000300023 · Cited by 2,342
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Systematic review finds overlapping reviews were not mentioned in every other overview
Pieper, D., Antoine, S.-L., Mathes, T., Neugebauer, E. A. M., & Eikermann, M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.007 · Cited by 1,318
A comparison of heterogeneity variance estimators in simulated random‐effects meta‐analyses
Langan, D., Higgins, J. P. T., Jackson, D., Bowden, J., Veroniki, A. A., Kontopantelis, E., Viechtbauer, W., & Simmonds, M. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1316 · Cited by 1,074
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902
Gates, M., Gates, A., Pieper, D., Fernandes, R. M., Tricco, A. C., Moher, D., Brennan, S. E., Li, T., Pollock, M., Lunny, C., et al. (2022) · BMJ · doi:10.1136/bmj-2022-070849 · Cited by 856
Regression Methods to Detect Publication and Other Bias in Meta‐Analysis
Sterne, J. A. C., & Egger, M. (2005) · Publication Bias in Meta‐Analysis · doi:10.1002/0470870168.ch6 · Cited by 826
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
A solution to minimum sample size for regressions
Jenkins, D. G., & Quintana-Ascencio, P. F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229345 · Cited by 665
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598
Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1131 · Cited by 517
Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2020) · Diabetes Care · doi:10.2337/dc19-1459 · Cited by 364
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356
Continuous glucose monitoring: A review of the technology and clinical use
Klonoff, D. C., Ahn, D., & Drincic, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.005 · Cited by 320
Lu, J., Wang, C., Shen, Y., Chen, L., Zhang, L., Cai, J., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1862 · Cited by 282
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
Jancev, M., Vissers, T. A. C. M., Visseren, F. L. J., van Bon, A. C., Serné, E. H., DeVries, J. H., de Valk, H. W., & van Sloten, T. T. (2024) · Diabetologia · doi:10.1007/s00125-024-06107-6 · Cited by 191
Evans, M., Welsh, Z., Ells, S., & Seibold, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00720-0 · Cited by 185
Allen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182
Poolsup, N., Suksomboon, N., & Kyaw, A. M. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-39 · Cited by 179
Lawton, J., Blackburn, M., Allen, J., Campbell, F., Elleri, D., Leelarathna, L., Rankin, D., Tauschmann, M., Thabit, H., & Hovorka, R. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0239-1 · Cited by 174
Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I. B., Robinson, N., Trence, D. L., Zelnick, L., & de Boer, I. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000991 · Cited by 162
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001115 · Cited by 157
Qu, Y., Jacober, S. J., Zhang, Q., Wolka, L. L., & DeVries, J. H. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0099 · Cited by 126
Seidu, S., Kunutsor, S. K., Ajjan, R. A., & Choudhary, P. (2024) · Diabetes Care · doi:10.2337/dc23-1520 · Cited by 124
Aronson, R., Brown, R. E., Chu, L., Bajaj, H. S., Khandwala, H., Abitbol, A., Malakieh, N., & Goldenberg, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14949 · Cited by 118
Janapala, R. N., Jayaraj, J. S., Fathima, N., Kashif, T., Usman, N., Dasari, A., Jahan, N., & Sachmechi, I. (2019) · Cureus · doi:10.7759/cureus.5634 · Cited by 117
Ferreira, R. O. M., Trevisan, T., Pasqualotto, E., Chavez, M. P., Marques, B. F., Lamounier, R. N., & van de Sande-Lee, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0390 · Cited by 92
Bergenstal, R. M., Mullen, D. M., Strock, E., Johnson, M. L., & Xi, M. X. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108106 · Cited by 87
Castellana, M., Parisi, C., Di Molfetta, S., Di Gioia, L., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001092 · Cited by 84
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa118 · Cited by 82
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Price, D. A., Deng, Q., Kipnes, M., & Beck, S. E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01086-y · Cited by 77
Uhl, S., Choure, A., Rouse, B., Loblack, A., & Reaven, P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad652 · Cited by 76
Moon, S. J., Kim, K., Lee, W. J., Lee, M. Y., Vigersky, R., & Park, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14852 · Cited by 69
Allen, N., Whittemore, R., & Melkus, G. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0088 · Cited by 59
Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30385-7 · Cited by 55
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
Ajjan, R. A., Heller, S. R., Everett, C. C., Vargas-Palacios, A., Higham, R., Sharples, L., Gorog, D. A., Rogers, A., Reynolds, C., Fernandez, C., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1219 · Cited by 44
Anjana, R. M., Kesavadev, J., Neeta, D., Tiwaskar, M., Pradeepa, R., Jebarani, S., Thangamani, S., Sastry, N. G., Brijendra Kumar, S., Ramu, M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0063 · Cited by 42
Chesser, H., Srinivasan, S., Puckett, C., Gitelman, S. E., & Wong, J. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221139873 · Cited by 40
Lu, J., Ying, Z., Wang, P., Fu, M., Han, C., & Zhang, M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15328 · Cited by 39
Sierra, J. A., Shah, M., Gill, M. S., Flores, Z., Chawla, H., Kaufman, F. R., & Vigersky, R. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2017.1390474 · Cited by 38
Mattishent, K., & Loke, Y. K. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.005 · Cited by 38
Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care
Simonson, G. D., Bergenstal, R. M., Johnson, M. L., Davidson, J. L., & Martens, T. W. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821998724 · Cited by 37
Kong, S.-Y., & Cho, M.-K. (2024) · Healthcare · doi:10.3390/healthcare12050571 · Cited by 36
Cowart, K., Updike, W., & Bullers, K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0345 · Cited by 36
Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift
Cox, D. J., Taylor, A. G., Moncrief, M., Diamond, A., Yancy, W. S., Hegde, S., & McCall, A. L. (2016) · Diabetes Care · doi:10.2337/dc15-2836 · Cited by 36
Rivera-Ávila, D. A., Esquivel-Lu, A. I., Salazar-Lozano, C. R., Jones, K., & Doubova, S. V. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00742-5 · Cited by 32
Kim, S. K., Kim, H. J., Kim, T., Hur, K. Y., Kim, S. W., Lee, M.-K., Min, Y.-K., Kim, K.-W., Chung, J. H., & Kim, J. H. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.449 · Cited by 23
Sergel-Stringer, O. T., Wheeler, B. J., Styles, S. E., Boucsein, A., Lever, C. S., Paul, R. G., Sampson, R., Watson, A., & de Bock, M. I. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01403-9 · Cited by 15
Rubelj, K. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.04.07 · Cited by 13
Research works printed but not linked: 98
- Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10:107–11. · DOI · Paper page
- Klein R, Klein BE. Relation of Glycemic Control to Diabetic Complications and Health Outcomes. Diabetes Care. 1998;21:C39–43. · DOI · Paper page
- Andersson DK, Svärdsudd K. Long-Term Glycemic Control Relates to Mortality in Type II Diabetes. Diabetes Care. 1995;18:1534–43. · DOI · Paper page
- Klonoff DC (2005) Continuous Glucose Monitoring. DIABETES CARE 28: · DOI · Paper page
- Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R. Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis. Diabetes Technol Ther. 2008;10:149–59. · DOI · Paper page
- Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer Adherence. 2014;8:237–46.
- Vettoretti M, Facchinetti A. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review. Biomed Eng OnLine. 2019;18:37. · DOI · Paper page
- Taylor PJ, Thompson CH, Brinkworth GD. Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review. J Diabetes Investig. 2018;9:713–25. · DOI · Paper page
- ten Brinke R, Dekker N, de Groot M, Ikkersheim D. Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality. Prim Care Diabetes. 2008;2:45–9. · DOI
- Luk AOY, Ma RCW, Lau ESH, Yang X, Lau WWY, Yu LWL, Chow FCC, Chan JCN, So W-Y. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2013;29:384–90. · DOI · Paper page
- Ishibashi F, Taniguchi M, Kosaka A, Uetake H, Tavakoli M. Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes. Diabetes Care. 2018;42:110–8. · DOI
- Genis-Mendoza AD, González-Castro TB, Tovilla-Vidal G, Juárez-Rojop IE, Castillo-Avila RG, López-Narváez ML, Tovilla-Zárate CA, Sánchez-de la Cruz JP, Fresán A, Nicolini H. Increased Levels of HbA1c in Individuals with Type 2 Diabetes and Depression: A Meta-Analysis of 34 Studies with 68,398 Participants. Biomedicines. 2022;10:1919. · DOI
- Arnold LW, Wang Z. The HbA1c and All-Cause Mortality Relationship in Patients with Type 2 Diabetes is J-Shaped: A Meta-Analysis of Observational Studies. Rev Diabet Stud RDS. 2014;11:138–52. · DOI · Paper page
- Wright LA-C, Hirsch IB (2017) Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. Diabetes Technol Ther 19:S-16 · DOI · Paper page
- Monnier L, Wojtusciszyn A, Colette C, Owens D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther. 2011;13:813–8. · DOI · Paper page
- Beyond A1C Writing Group. Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics. Diabetes Care. 2018;41:e92–4. · DOI · Paper page
- Raj R, Mishra R, Jha N, Joshi V, Correa R, Kern PA. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Res Care. 2022;10:e002573. · DOI
- Lee I, Probst D, Klonoff D, Sode K. Continuous glucose monitoring systems - Current status and future perspectives of the flagship technologies in biosensor research -. Biosens Bioelectron. 2021;181:113054. · DOI · Paper page
- Di Molfetta S, Caruso I, Cignarelli A, Natalicchio A, Perrini S, Laviola L, Giorgino F. Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2023;25:1301–10. · DOI
- Ang E, Lee ZX, Moore S, Nana M. Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life. J Diabetes Complications. 2020;34: 107559. · DOI · Paper page
- Gao Y, Zhou M, Xu X, Chen WY. Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials. J Diabetes Complications. 2022;36:108314. · DOI
- Asarani NAM, Reynolds AN, Boucher SE, de Bock M, Wheeler BJ. Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies. J Diabetes Sci Technol. 2020;14:328–37. · DOI · Paper page
- Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019;2019:e4684815. · DOI · Paper page
- Hoeks LBEA, Greven WL, de Valk HW. Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review. Diabet Med. 2011;28:386–94. · DOI · Paper page
- Dicembrini I, Mannucci E, Monami M, Pala L. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Obes Metab. 2019;21:2619–25. · DOI · Paper page
- Gandhi GY, Kovalaske M, Kudva Y, et al. Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Trials. J Diabetes Sci Technol. 2011;5:952–65. · DOI · Paper page
- Pollock M, Fernandes R, Becker L, Pieper D, Hartling L Chapter V: Overviews of Reviews In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.
- Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. · DOI · Paper page
- Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG, Group ISTC, Group ECSTC (2003) Evaluating non-randomised intervention studies. Health Technol Assess Winch Engl 7:iii–173 · DOI · Paper page
- Pérez-Bracchiglione J, Meza N, Bangdiwala SI, Niño de Guzmán E, Urrútia G, Bonfill X, Madrid E. Graphical Representation of Overlap for OVErviews: GROOVE tool. Res Synth Methods. 2022;13:381–8. · DOI · Paper page
- Tan BL, Tong HJ, Narashimhan S, Banihani A, Nazzal H, Duggal MS. Tooth autotransplantation: An umbrella review. Dent Traumatol. 2023;39:2–29. · DOI
- Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36:1–48. · DOI · Paper page
- Hariton E, Locascio JJ. Randomised controlled trials—the gold standard for effectiveness research. BJOG Int J Obstet Gynaecol. 2018;125:1716. · DOI · Paper page
- Baujat B, Mahé C, Pignon J-P, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002;21:2641–52. · DOI · Paper page
- Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94. · DOI · Paper page
- Aggarwal A, Pathak S, Goyal R. Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review. Diabetes Res Clin Pract. 2022;186:109825. · DOI
- Azhar A, Gillani SW, Mohiuddin G, Majeed RA. A systematic review on clinical implication of continuous glucose monitoring in diabetes management. J Pharm Bioallied Sci. 2020;12:102. · DOI
- García-Lorenzo B, Rivero-Santana A, Vallejo-Torres L, Castilla-Rodríguez I, García-Pérez S, García-Pérez L, Perestelo-Pérez L. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain. J Eval Clin Pract. 2018;24:772–81. · DOI
- Kieu A, King J, Govender RD, Östlundh L. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. 2023;17:762–74. · DOI
- Meade LT. The use of continuous glucose monitoring in patients with type 2 diabetes. Diabetes Technol Ther. 2012;14:190–5. · DOI
- Park C, Le QA. The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis. Diabetes Technol Ther. 2018;20:613–21. · DOI · Paper page
- Torres Roldan VD, Urtecho M, Nayfeh T, et al. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia. J Clin Endocrinol Metab. 2023;108:592–603. · DOI
- Blackberry ID, Furler JS, Ginnivan LE, et al. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study. Diabetes Res Clin Pract. 2014;106:247–55. · DOI
- Cai ZQ, Wu S. Observation on the effect of scanning glucose monitoring system in diabetic participants. Contemp Med. 2019;25:173–4.
- Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes. Diabetes Ther. 2017;8:573–86. · DOI · Paper page
- Liu Q, Xuan W, Zhang Z. Analysis of the effect of different blood glucose monitoring methods on blood glucose control in participants with type 2 diabetes mellitus. Med Innov China. 2020;17:136–9.
- Tildesley HD, Wright AM, Chan JHM, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, Tang TS, White AS. A Comparison of Internet Monitoring with Continuous Glucose Monitoring in Insulin-Requiring Type 2 Diabetes Mellitus. Can J Diabetes. 2013;37:305–8. · DOI
- Yang HL. The application of ambulatory glucose monitoring in participants with type 2 diabetes mellitus. Med Forum. 2021;25:1031–3.
- Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42:1178–84. · DOI · Paper page
- Yeoh E, Lim BK, Fun S, Tong J, Yeoh LY, Sum CF, Subramaniam T, Lim SC. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients. Nephrology. 2018;23:264–8. · DOI · Paper page
- Zhang W, Liu P, Ma SR, et al. The value of rapid glucose monitoring in participants with type 2 diabetes mellitus. Chin J Cardiovasc Rehabil. 2021;30:416–9.
- Zhang X, Yan Y, Peng L, et al. The application of transient scanning glucose monitoring system in elderly diabetic participants. Med Inf. 2021;34:180–2.
- Zhou M, Li X, Tu N, et al. The application of ambulatory glucose monitoring system in the management of type 2 diabetes mellitus. Chin J Prev Control Chronic Dis. 2021;29:700–2.
- Zhou M, Tu N, Xu X, et al. Effectiveness of FGMS-based combined health coaching techniques in the management of participants with type 2 diabetes mellitus. Chin J Gerontol. 2020;40:3839–43.
- Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, Attali J-R, Pariès J, Schaepelynck-Bélicar P. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay®) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab. 2009;35:312–8. · DOI · Paper page
- Ilany J, Bhandari H, Nabriski D, Toledano Y, Konvalina N, Cohen O. Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: A randomized, phase IV study. Diabetes Obes Metab. 2018;20:1186–92. · DOI
- Tang TS, Digby EM, Wright AM, Chan JHM, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, White AS, Tildesley HD. Real-time continuous glucose monitoring versus internet-based blood glucose monitoring in adults with type 2 diabetes: A study of treatment satisfaction. Diabetes Res Clin Pract. 2014;106:481–6. · DOI
- Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes. Diabetes Care. 2011;35:32–8. · DOI · Paper page
- Ajjan RA, Abougila K, Bellary S, Collier A, Franke B, Jude EB, Rayman G, Robinson A, Singh BM. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients. Diab Vasc Dis Res. 2016;13:211–9. · DOI · Paper page
- Fantasia KL, Stockman M-C, Ju Z, Ortega P, Crable EL, Drainoni M-L, Walkey AJ, Bergstrom M, O’Brien K, Steenkamp D. Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: Results of a clinical pilot program. J Clin Transl Endocrinol. 2021;24:100254.
- Kesavadev J, Vigersky R, Shin J, Pillai PBS, Shankar A, Sanal G, Krishnan G, Jothydev S. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation. Adv Ther. 2017;34:1918–27. · DOI
- Sato J, Kanazawa A, Ikeda F, et al. Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial. J Int Med Res. 2016;44:109–21. · DOI · Paper page
- Thielen V, Scheen A, Bringer J, Renard E. Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring. Diabetes Metab. 2010;36:240–3. · DOI
- Speight J, Holmes-Truscott E, Thuraisingam S, et al. Impact of quarterly professional-mode flash glucose monitoring in adults with type 2 diabetes in general practice (GP-OSMOTIC): Secondary psychological and self-care outcomes of a pragmatic, open-label, 12-month, randomised controlled trial. Diabetes Res Clin Pract. 2021;179:108994. · DOI
- Taylor PJ, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Wittert G, Brinkworth GD. Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study. Diabetes Ther. 2019;10:509–22. · DOI · Paper page
- Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale. Diabetes Care. 2005;28:626–31. · DOI · Paper page
- Group TW. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998;28:551–8. · DOI · Paper page
- Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care. 1999;22:530–2. · DOI · Paper page
- Lind M, Odén A, Fahlén M, Eliasson B. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia. 2010;53:1093–8. · DOI
- Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard J-P. How can we measure insulin sensitivity/resistance? Diabetes Metab. 2011;37:179–88. · DOI · Paper page
- McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460–4. · DOI · Paper page
- Edelman SV, Argento NB, Pettus J, Hirsch IB. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring. Diabetes Care. 2018;41:2265–74. · DOI · Paper page
- Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565–8. · DOI · Paper page
- Probst P, Knebel P, Grummich K, Tenckhoff S, Ulrich A, Büchler MW, Diener MK. Industry Bias in Randomized Controlled Trials in General and Abdominal Surgery. Ann Surg. 2016;264:87–92. · DOI
- Lexchin J. Sponsorship bias in clinical research. Int J Risk Saf Med. 2012;24:233–42. · DOI
- Landefeld CS. Commercial support and bias in pharmaceutical research. Am J Med. 2004;117:876–8. · DOI
- Jin X, Yang X, Xu Y, et al. Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes. Diabetol Metab Syndr. 2023;15:92. · DOI
- Gabbay MAL, Rodacki M, Calliari LE, et al. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. Diabetol Metab Syndr. 2020;12:22. · DOI · Paper page
- Dovc K, Battelino T. Time in range centered diabetes care. Clin Pediatr Endocrinol. 2021;30:1–10. · DOI
- Soni A, Wright N, Agwu J, et al. A practical approach to continuous glucose monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in children and young people with Type 1 diabetes. Diabetes Res Clin Pract. 2022;184:109196. · DOI
- Crocket H, Elbashy MM, Kavanagh T, et al. Parental experiences of short term supported use of a do-it-yourself continuous glucose monitor (DIYrtCGM): A qualitative study. Diabet Med. 2022;39:e14731. · DOI
- Vloemans AF, van Beers C, a. J, de Wit M, Cleijne W, Rondags SM, Geelhoed-Duijvestijn PH, Kramer MHH, Serné EH, Snoek FJ,. Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study. Diabet Med. 2017;34:1470–6. · DOI
- Polonsky WH, Hessler D. What Are the Quality of Life-Related Benefits and Losses Associated with Real-Time Continuous Glucose Monitoring? A Survey of Current Users. Diabetes Technol Ther. 2013;15:295–301. · DOI · Paper page
- Litchman ML, Allen NA. Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study. J Diabetes Sci Technol. 2017;11:988–95. · DOI
- Messer LH, Johnson R, Driscoll KA, Jones J. Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes. Diabet Med. 2018;35:409–18. · DOI
- Steinberg E, Greenfield S, Wolman DM, Mancher M, Graham R, others (2011) Clinical Practice Guidelines We Can Trust. In: Institute Of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. National Academies Press
- Kataoka Y, Oide S, Ariie T, Tsujimoto Y, Furukawa TA. The Methodological Quality Score of COVID-19 Systematic Reviews is Low, Except for Cochrane Reviews: A Meta-epidemiological Study. Ann Clin Epidemiol. 2021;3:46–55. · DOI
- Siemens W, Schwarzer G, Rohe MS, Buroh S, Meerpohl JJ, Becker G. Methodological quality was critically low in 9/10 systematic reviews in advanced cancer patients—A methodological study. J Clin Epidemiol. 2021;136:84–95. · DOI
- Pandis N, Fleming PS, Worthington H, Salanti G. The Quality of the Evidence According to GRADE Is Predominantly Low or Very Low in Oral Health Systematic Reviews. PLoS ONE. 2015;10:e0131644. · DOI
- Beck RW. Closing in on closed-loop systems for type 2 diabetes. Nat Med. 2023;29:33–4. · DOI
- Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, Evans ML, Coll AP, Hovorka R. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5:117–24. · DOI · Paper page
- Boughton CK, Tripyla A, Hartnell S, Daly A, Herzig D, Wilinska ME, Czerlau C, Fry A, Bally L, Hovorka R. Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med. 2021;27:1471–6. · DOI · Paper page
- Sharma P, Singh S, Thakur V, Sharma N, Grewal AS. Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. Obes Med. 2021;23:100329. · DOI
- Yamada K, Nakayama H, Yoshinobu S, et al. Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring. J Diabetes Investig. 2015;6:699–707. · DOI
- Torimoto K, Okada Y, Koikawa K, Tanaka Y. Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring. Diabetol Metab Syndr. 2017;9:60. · DOI
- Hirsch IB, Parkin CG, Cavaiola TS, Bergenstal RM Use of continuous glucose monitoring when initiating glucagon-like peptide-1 receptor agonist therapy in insulin-treated diabetes. Diabetes Obes Metab. https://doi.org/10.1111/dom.15883 · DOI
- Abdelgadir E, Rashid F, Bashier A, Al Saeed M, Khalifa A, Alawadi F, Hassanein M. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes. Diabetes Metab Syndr Clin Res Rev. 2019;13:2927–32. · DOI
- Hermanns N, Ehrmann D, Schipfer M, Kröger J, Haak T, Kulzer B. The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial. Diabetes Res Clin Pract. 2019;150:111–21. · DOI · Paper page
Cited by
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0561 · Cited by 11
Metadata
- Authors
- Tan, Y. Y., Suan, E., Koh, G. C. H., Suhairi, S. B., & Tyagi, S.
- Venue
- Archives of Public Health
- Published
- 2024-12-02
- Volume
- 82
- Issue
- 1
- ISSN
- 2049-3258
- Cited by
- 35
- References
- 61
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.